Literature DB >> 6757715

Mechanism of the anticoagulant action of heparin.

I Björk, U Lindahl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6757715     DOI: 10.1007/bf00421226

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


× No keyword cloud information.
  147 in total

1.  The separation of active and inactive forms of heparin.

Authors:  L H Lam; J E Silbert; R D Rosenberg
Journal:  Biochem Biophys Res Commun       Date:  1976-03-22       Impact factor: 3.575

Review 2.  Antithrombin III and heparin.

Authors:  T W Barrowcliffe; E A Johnson; D Thomas
Journal:  Br Med Bull       Date:  1978-05       Impact factor: 4.291

3.  Anticoagulant action of heparin.

Authors:  P S Damus; M Hicks; R D Rosenberg
Journal:  Nature       Date:  1973-12-07       Impact factor: 49.962

4.  Binding of heparin on the surface of cultured human endothelial cells.

Authors:  B Glimelius; C Busch; M Höök
Journal:  Thromb Res       Date:  1978-05       Impact factor: 3.944

5.  A surprising new protein superfamily containing ovalbumin, antithrombin-III, and alpha 1-proteinase inhibitor.

Authors:  L T Hunt; M O Dayhoff
Journal:  Biochem Biophys Res Commun       Date:  1980-07-31       Impact factor: 3.575

6.  Changes in numbers and heparin content of peritoneal fluid mast cells of growing rats measured by flow cytofluorometry.

Authors:  G Berlin; L Enerbäck
Journal:  J Histochem Cytochem       Date:  1978-01       Impact factor: 2.479

7.  Production of blood coagulation factor V and tissue thromboplastin by macrophages in vitro.

Authors:  B Osterud; J Bögwald; U Lindahl; R Seljelid
Journal:  FEBS Lett       Date:  1981-05-05       Impact factor: 4.124

8.  Synthesis of heparin-sepharoses and their binding with thrombin and antithrombin-heparin cofactor.

Authors:  I Danishefsky; F Tzeng; M Ahrens; S Klein
Journal:  Thromb Res       Date:  1976-02       Impact factor: 3.944

9.  Evidence for the formation of an ester between thrombin and heparin cofactor.

Authors:  W G Owen
Journal:  Biochim Biophys Acta       Date:  1975-10-20

10.  Fractionation of low molecular weight heparin species and their interaction with antithrombin.

Authors:  D Beeler; R Rosenberg; R Jordan
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

View more
  66 in total

1.  Heparin sequencing brings structure to the function of complex oligosaccharides.

Authors:  M A Nugent
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

2.  The C-terminal fragment of axon guidance molecule Slit3 binds heparin and neutralizes heparin's anticoagulant activity.

Authors:  Eduard Condac; Heather Strachan; Gerardo Gutierrez-Sanchez; Benjamin Brainard; Christina Giese; Christian Heiss; Darryl Johnson; Parastoo Azadi; Carl Bergmann; Ron Orlando; Charles T Esmon; Job Harenberg; Kelley Moremen; Lianchun Wang
Journal:  Glycobiology       Date:  2012-05-28       Impact factor: 4.313

3.  Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin.

Authors:  B Bray; D A Lane; J M Freyssinet; G Pejler; U Lindahl
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

4.  Investigation of Luminescence Characteristics of Osmium(II) Complexes in the Presence of Heparin Polyanions.

Authors:  Yixi Xie; Yu Lei; Shalini Shah; Hao Wu; Jian Wu; Elise Megehee; Enju Wang
Journal:  Int J Anal Chem       Date:  2013-07-16       Impact factor: 1.885

5.  Investigation of the heparin-thrombin interaction by dynamic force spectroscopy.

Authors:  Congzhou Wang; Yingzi Jin; Umesh R Desai; Vamsi K Yadavalli
Journal:  Biochim Biophys Acta       Date:  2015-01-31

6.  Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.

Authors:  M F Scully; V Ellis; N Seno; V V Kakkar
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

Review 7.  In Vivo Chemical Sensors: Role of Biocompatibility on Performance and Utility.

Authors:  Robert J Soto; Jackson R Hall; Micah D Brown; James B Taylor; Mark H Schoenfisch
Journal:  Anal Chem       Date:  2016-11-21       Impact factor: 6.986

8.  Comparison of the behaviour in vivo of two molecular forms of antithrombin III.

Authors:  T H Carlson; A C Atencio; T L Simon
Journal:  Biochem J       Date:  1985-02-01       Impact factor: 3.857

Review 9.  The use of novel oral anticoagulants for thromboprophylaxis after elective major orthopedic surgery.

Authors:  Saleh Rachidi; Ehab Saad Aldin; Charles Greenberg; Barton Sachs; Michael Streiff; Amer M Zeidan
Journal:  Expert Rev Hematol       Date:  2013-12       Impact factor: 2.929

10.  Arginine residues are critical for the heparin-cofactor activity of antithrombin III.

Authors:  A M Jorgensen; C L Borders; W W Fish
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.